GILEAD SCIENCES, INC.
CIK 882095 · last filed 2026-05-27
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.05B
Companies
5
Total Filings
15
Lifetime Open-Market Net
$628.11M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ASMB | 10%+ Owner | 4,977,089 | $26.21 | $130.45M | $20.10M | 4 | 2026-05-27 |
| XLO | 10%+ Owner | 650,389 | $9.09 | $5.91M | $2.20M | 5 | 2026-02-17 |
| RCUS | 10%+ Owner | 31,424,760 | $28.05 | $881.46M | $574.80M | 4 | 2025-02-20 |
| KYTX | 10%+ Owner | 4,126,119 | $8.00 | $33.01M | $20.02M | 1 | 2024-02-13 |
| Kalaris Therapeutics, Inc. (ALVR) Delisted | 10%+ Owner | 723,273 | $9.81 | $7.10M | $10.99M | 1 | 2023-06-28 |
Recent Filings · Page 2 of 2
15 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-02-13 | KYTX | Mixed | +4,126,119 | $20.02M | EDGAR |
| 2024-01-31 | RCUS | Buy (P) | +15,238,095 | $320.00M | EDGAR |
| 2023-06-30 | RCUS | Buy (P) | +1,010,000 | $19.45M | EDGAR |
| 2023-06-28 | Kalaris Therapeutics, Inc. (ALVR) Delisted | Buy (P) | +2,930,870 | $10.99M | EDGAR |
| 2021-02-02 | RCUS | Buy (P) | +5,650,000 | $220.35M | EDGAR |
Showing 11–15 of 15
Prev
Page 2 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.